1149336 Ontario, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for 1149336 Ontario, Inc..The latest application filed is for "method of regulating glucose metabolism, and reagents related thereto".
- 1149336 Ontario, Inc. - Toronto CA
- 1149336 Ontario Inc. - CA CA
- 1149336 Ontario Inc. - Ontario CA
- 1149336 Ontario Inc. -
| Patent | Date |
|---|---|
| Method of Regulating Glucose Metabolism, and Reagents Related Thereto App 20160000857 - Bachovchin; William W. ; et al. | 2016-01-07 |
| Methods Of Enhancing Functioning Of The Large Intestine App 20150290295 - Drucker; Daniel J. | 2015-10-15 |
| Methods of regulating glucose metabolism, and reagents related thereto Grant 9,044,424 - Bachovchin , et al. June 2, 2 | 2015-06-02 |
| Glucagon-like peptide-2 analogs Grant 8,933,039 - Drucker , et al. January 13, 2 | 2015-01-13 |
| Glucagon-like peptide-2 analogs Grant 8,846,625 - Drucker , et al. September 30, 2 | 2014-09-30 |
| Methods Of Enhancing Functioning Of The Large Intestine App 20140213518 - Drucker; Daniel J. | 2014-07-31 |
| Methods of Regulating Glucose Metabolism, and Reagents Related Thereto App 20140178472 - Bachovchin; William W. ; et al. | 2014-06-26 |
| Methods of enhancing functioning of the large intestine Grant 8,603,976 - Drucker December 10, 2 | 2013-12-10 |
| Method of regulating glucose metabolism, and reagents related thereto Grant 8,513,190 - Bachovchin , et al. August 20, 2 | 2013-08-20 |
| Glucagon-like Peptide-2 Analogs App 20130203673 - Drucker; Daniel J. ; et al. | 2013-08-08 |
| Methods Of Enhancing Functioning Of The Large Intestine App 20120328527 - Drucker; Daniel J. | 2012-12-27 |
| Method of regulating glucose metabolism, and reagents related thereto Grant 8,318,669 - Bachovchin , et al. November 27, 2 | 2012-11-27 |
| Methods of enhancing functioning of the large intestine Grant 8,278,273 - Drucker October 2, 2 | 2012-10-02 |
| Methods Of Enhancing Functioning Of The Large Intestine App 20110275568 - Drucker; Daniel J. | 2011-11-10 |
| Glucagon-like Peptide-2 And Its Therapeutic Use App 20110223108 - Drucker; Daniel J. | 2011-09-15 |
| Methods of enhancing functioning of the large intestine Grant 7,960,344 - Drucker June 14, 2 | 2011-06-14 |
| Enhancement of GLP-2 activity of suppressing appetite Grant 7,862,824 - Drucker , et al. January 4, 2 | 2011-01-04 |
| Method of regulating glucose metabolism, and reagents related thereto Grant 7,829,530 - Bachovchin , et al. November 9, 2 | 2010-11-09 |
| Methods Of Enhancing Functioning Of The Large Intestine App 20100119453 - Drucker; Daniel J. | 2010-05-13 |
| Method of regulating glucose metabolism, and reagents related thereto Grant 7,459,428 - Bachovchin , et al. December 2, 2 | 2008-12-02 |
| Methods of enhancing functioning of the large intestine App 20070129304 - Drucker; Daniel J. | 2007-06-07 |
| Methods of enhancing functioning of the large intestine Grant 7,176,182 - Drucker February 13, 2 | 2007-02-13 |
| Glucagon-like peptide-2 and its therapeutic use Grant 7,049,284 - Drucker May 23, 2 | 2006-05-23 |
| Glucagon-like peptide-2 and its therapeutic use App 20060105954 - Drucker; Daniel J. | 2006-05-18 |
| Method of regulating glucose metabolism, and reagents related thereto Grant 6,890,898 - Bachovchin , et al. May 10, 2 | 2005-05-10 |
| Method of regulating glucose metabolism, and reagents related thereto Grant 6,803,357 - Bachovchin , et al. October 12, 2 | 2004-10-12 |
| Enhancement of GLP-2 activity App 20040198642 - Drucker, Daniel J. ; et al. | 2004-10-07 |
| Glucagon-like peptide-2 and its therapeutic use App 20030158101 - Drucker, Daniel J. | 2003-08-21 |
| Methods of enhancing functioning of the large intestine Grant 6,586,399 - Drucker July 1, 2 | 2003-07-01 |
| Antagonists of intestinotrophic GLP-2 peptides App 20030109449 - Drucker, Daniel J. ; et al. | 2003-06-12 |
| Antagonists of intestinotrophic GLP-2 peptides Grant 6,489,295 - Drucker , et al. December 3, 2 | 2002-12-03 |
| Enhancement of GLP-2 activity App 20020123461 - Drucker, Daniel J. ; et al. | 2002-09-05 |
| Methods of enhancing functioning of the large intestine Grant 6,297,214 - Drucker October 2, 2 | 2001-10-02 |
| Methods of enhancing functioning of the upper gastrointestinal tract Grant 6,051,557 - Drucker April 18, 2 | 2000-04-18 |
| Antagonists of intestinotrophic GLP-2 peptides Grant 5,994,500 - Drucker , et al. November 30, 1 | 1999-11-30 |
| Glucagon-like peptide-2 and its therapeutic use Grant 5,990,077 - Drucker November 23, 1 | 1999-11-23 |
| Method of using exendin and GLP-1 to affect the central nervous system Grant 5,846,937 - Drucker December 8, 1 | 1998-12-08 |
| Glucagon-like peptide-2 and its therapeutic use Grant 5,834,428 - Drucker November 10, 1 | 1998-11-10 |
| Glucagon-like peptide-2 analogs Grant 5,789,379 - Drucker , et al. August 4, 1 | 1998-08-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 